Make a Booking Track a Shipment Request a Quote Contact Us for More Information

The Global Clinical Trial & Healthcare Specialist

PDP Couriers is a truly global specialist Clinical Trial and Healthcare courier. It is fast becoming the number one choice for Clinical Trial Project managers and Logistics professionals... more

Latest News

This new visual identity reflects the alliance of the various branches of the group inside one singl... more

Latest News from PDP Couriers

Latest News

Air Liquide announces the acquisition of PDP Couriers, a service leader specialized in temperature-controlled logistics for the pharmaceutical industry

CRYO International, an Air Liquide group subsidiary specializing in temperature-controlled logistics solutions, has just acquired PDP Couriers, a major player in the customized transport of high value- added products for the pharmaceutical and biotechnology industries.
Based in the UK, PDP Couriers has over 120 employees at 14 locations worldwide. The company generated revenues of approximately 21 million Euros in 2015. PDP Couriers has grown significantly in Eastern Europe, Latin America and Asia over the past few years.
Safety, punctuality and reliability are key in the transport sector for temperature-sensitive samples and products in the pharmaceutical industry, particularly in the clinical research area. PDP Couriers is one of the specialists in this sector with an international presence.
This acquisition is a new phase in the strategy initiated in the past few years by CRYO International, whose goal is to be able to offer its customers innovative and customized temperature-controlled logistics solutions anywhere in the world.

Guy Salzgeber, Senior Vice-President, Europe Industries, and a member of the Air Liquide groups Executive Committee, commented: Cryo International illustrates the Groups intention to seize growth opportunities in adjacent markets. The acquisition of PDP Couriers is very much in line with this approach. We are delighted to welcome these new employees to Air Liquide.

Cedric Picaud, Chief Executive Officer of CRYO International, added: With this acquisition we are combining our know-how in CARBOGLACETM and temperature-controlled solutions with a premium logistics service. This expansion in our activities supports the geographical growth of our customers and their need for services with increased added value.

CARBOGLACETM (or dry ice) is the solid form of carbon dioxide (CO2). Its temperature of -78 degrees Celsius is ideal for maintaining the integrity of sensitive products over several days. CARBOGLACETM is used widely for transport and logistics in the pharmaceutical and agri-food industries, within the Groups Industrial Merchant Business Line.

Who are CRYO International
CRYO International is the parent company of CRYO EXPRESS. For more than 15 years, CRYO EXPRESS, a temperature-controlled solutions specialist, has been supplying cryogenic products (CARBOGLACETM, liquid nitrogen) and offering customized logistics solutions for transporting pharmaceuticals

Corporate Communications
Caroline Philips
+33 (0)1 40 62 50 84
Aurelie Wayser-Langevin
+33 (0)1 40 62 56 19

Investor Relations
Aude Rodriguez
+33 (0)1 40 62 57 08
Erin Sarret
+33 (0)1 40 62 57 37
Louis Laffont
+33 (0)1 40 62 57 18
CRYO International
Karine Gradziel
+33 (0)1 70 32 15 17

About Air Liquide

A World leader in gases, technologies and services for Industry and Health, Air Liquide is present in 80 countries with more than 50,000 employees and serves more than 2 million customers and patients. Oxygen, nitrogen and hydrogen have been at the core of the companys activities since its creation in 1902. Air Liquides ambition is to be the leader in its industry, delivering long-term performance and acting responsibly.

Air Liquide ideas create value over the long term. At the core of the companys development are the commitment and constant inventiveness of its people.

Air Liquide anticipates the challenges of its markets, invests locally and globally, and delivers high-quality solutions to its customers and patients, and the scientific community.

The company relies on competitiveness in its operations, targeted investments in growing markets and innovation to deliver profitable growth over the long-term.

Air Liquides revenues amounted to 15.4 billion Euros in 2014, and its solutions that protect life and the environment represented more than 40% of sales. Air Liquide is listed on the Paris Euronext stock exchange (compartment A) and is a member of the CAC 40 and Dow Jones Euro Stoxx 50 indexes.

« back to news